SEARCH RESULT

Total Matching Records found : 1047

Looking for indicators of progress beyond GDP-Kirthi V Rao and Vidya Krishnan

-Live Mint The OECD forum is discussing how to make the aspirations of the common man relevant to policymaking New Delhi: In the face of a deepening economic crisis and social resistance to austerity measures, world leaders are considering a collective experiment to include parameters such as well-being and happiness in national and international statistics. The Organisation for Economic Co-operation and Development’s (OECD) World Forum on Measuring Well-being for Development Policy Making being...

More »

Health ministry pushes for end to sale of branded drugs -Kounteya Sinha

-The Times of India Medicines in India may not be sold under brand names in the near future. In its biggest move to push generic drugs and do away with brand names, the Union health ministry has ordered states to stop issuing licence for the manufacture or sale of drugs on the basis of their brand name. All pharmaceutical firms applying for licence to market or manufacture fixed dose combination (FDC) drugs will...

More »

The dark underbelly of India’s clinical trials business-Malia Politzer and Vidya Krishnan

-Live Mint Incidents at Bhopal and Indore highlight irregularities and ethical violations in some trials In 2004, doctors at the Bhopal Memorial Hospital and Research Centre (BMHRC), established exclusively for treating the victims of the 1984 gas leak, recruited unsuspecting survivors for clinical trials without their knowledge or consent; 14 participants died during the course of the trials. Together with the episode in Indore’s Maharaja Yashwantrao Hospital (that Mint reported on 10...

More »

Clinical trials: Regulating chaos-Vidya Krishnan and Malia Politzer

-Live Mint The first in a two-part series examining the opaque world of clinical trials in India  A hospital in Indore has been able to get away with unethical medical trials in which 32 people have died over five years, according to the state government. This despite several investigations, a state government ban and Supreme Court strictures—a classic example of the lawless nature of the clinical trial business in India.   Lata Mehra, who...

More »

A short-sighted cap-Chandra M Gulhati

-The Indian Express The government’s proposal to price-control certain drugs will create more problems than it will solve From clothes to cars, prices of consumer products the world over are determined taking into account input costs, margins and competition, popularly called the cost-based pricing system. Departing from this sound, fair, tried and tested principle of commerce, the government’s new drug pricing policy, approved by the Group of Ministers headed by Sharad Pawar,...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close